Mathias Haarhaus

Nephrologist, striving to improve treatment and prevention of CKD-MBD, cardiovascular complications and mortality.

[Mónica Furlano MD, PhD @m_furlano]

🏆Congratulations @mjlloretcora !!!! #bestabstract award in the 6º EUROD Winter Meeting #CKDMBD @ERAkidney @SENefrologia @nefrocat @senjoven

[Justine Bacchetta Guidici @Bacchetta_J]

Amazing talk by @LucileFigueres on calcium and magnésium in CKD during the EUROD meeting in Leuven! #EUROD @FiliereOSCAR @FiliereORKiD

[Mathias Haarhaus @mathaarhaus]

Advanced CKD no longer an obstacle for osteoporosis treatment? See new recommendations by IOF & ERA-EDTA: Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism | SpringerLink https://t.co/ro4jrzZe48

[Mathias Haarhaus @mathaarhaus]

Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment - Kidney International. The underlying cause may determine the association of low bone turnover with outcome, which is not always unfafourable. https://t.co/63UkqY0rxE

[Mathias Haarhaus @mathaarhaus]

Fresh from the press: the joint statement of IOF and ERA-EDTA on management of osteoporosis in advanced CKD.

[Mathias Haarhaus @mathaarhaus]

European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D | Nephrology Dialysis Transplantation | Oxford Academic. https://t.co/sowAlpKtYr

[Mathias Haarhaus @mathaarhaus]

ASN in beautiful Washington D.C.
Proud team presenting exciting new data on a strong association of serum ALP with cognitive impairment (R^2=0.96) in the baseline assessment of BETonMACE

[Mathias Haarhaus @mathaarhaus]

First report ever of a clinical intervention that lowers alkaline phosphatase and improves cardiovascular outcome in patients with CVD.

Is this the humble start of a new therapeutic paradigm: targeting ALP for cardiovascular risk reduction?

[Mathias Haarhaus @mathaarhaus]

@drjuliashaw @Jeffrey_Beall They still send invitations following the same pattern. A pity they made it to PubMed https://t.co/szd7PfN6iE

[Mathias Haarhaus @mathaarhaus]

Joint effort to improve outcome for CKD patients. https://t.co/yjhgRikKx9

[Kam Kalantar-Zadeh, MD, MPH, PhD @kamkalantar]

Nature Reviews Nephrol hot: Alkaline Phosphatase (#ALP) strikes back in CKD a novel treatment target for CV disease https://t.co/aLsqaP2zBv

[Mathias Haarhaus @mathaarhaus]

What's hot in CKD? Nature Rev Nephrol: Targeting ALP to improve survival.